A Phase 2b, Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Sorafenib (SOR) Compared With Placebo (PBO) When Administered in Combination With Chemotherapy (Modified FOLFOX6) for First-line Treatment (tx) of Patients (Pts) With Metastatic Colorectal Cancer (mCRC). The RESPECT Trial

Josep M. Tabernero, Rocio García‐Carbonero, C.H. Könne et al. · European Journal of Cancer · 2011

Cited by 8 works. doi:10.1016/s0959-8049(11)70118-6

Authors